Citigroup
VYNT

Citigroup’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Citigroup’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-160
Closed -$1K – 6835
2022
Q1 		$1K Buy
+160
New +$930 ﹤0.01% 6250
2021
Q2 		– Sell
-2,000
Closed -$46K – 6508
2021
Q1 		$46K Buy
+2,000
New +$50.7K ﹤0.01% 4755
2016
Q1 		– Sell
-3
Closed -$1K – 7864
2015
Q4 		$1K Buy
+3
New +$2.17K ﹤0.01% 7443
2015
Q3 		– Sell
-1
Closed -$1.53K – 7833
2015
Q2 		$2K Buy
+1
New +$1.55K ﹤0.01% 7180
2015
Q1 		– Sell
-1
Closed -$1K – 7506
2014
Q4 		$1K Buy
+1
New +$1K ﹤0.01% 7011
2014
Q3 		– Sell
-4
Closed -$7K – 7370
2014
Q2 		$7K Buy
+4
New +$7.61K ﹤0.01% 6333
2014
Q1 		– Sell
-3
Closed -$7K – 7255
2013
Q4 		$7K Buy
+3
New +$6.48K ﹤0.01% 6542

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JSC
Jackson Square Capital San Francisco, California $719M AUM 144.18% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CCB
Country Club Bank Kansas City, Missouri $1.69B AUM 16.93% 1-Year Est. Return

Citigroup's VYNT Position: Q2 2022 in Review

Citigroup sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2022, closing a stake of 160 shares — an estimated $1K sold.

Citigroup first reported a position in VYNT in Q4 2013 and held it in 7 quarters. The position peaked at $46K in Q1 2021. 21 funds tracked by Wall St. Rank hold VYNT as of Q2 2022.

  • Citigroup reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Citigroup sold 160 Vyant Bio, Inc. Common Stock shares in Q2 2022, an estimated $1K.
  • Citigroup first reported a position in Vyant Bio, Inc. Common Stock in Q4 2013 and held it in 7 quarters.
  • Citigroup's Vyant Bio, Inc. Common Stock position peaked at $46K in Q1 2021.
  • 21 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2022.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.